Cannabis-based Products: Medicinal Use

Health and Social Care – in the House of Commons on 15th January 2019.

Alert me about debates like this

Photo of Ronnie Cowan Ronnie Cowan Shadow SNP Spokesperson (Infrastructure)

What guidance his Department has issued to clinicians on the prescription of cannabis-based products for medicinal use.

Photo of Alistair Carmichael Alistair Carmichael Liberal Democrat Chief Whip, Liberal Democrat Spokesperson (Northern Ireland)

What recent clinical advice he has sought on the licensing of cannabis oil for medicinal purposes.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The Government acted swiftly to change the law to allow cannabis-based products to be prescribed for those patients who might benefit, with advice from the chief medical officer and the Advisory Council on the Misuse of Drugs. NHS England and the CMO have written to clinicians in England highlighting the interim clinical guidance available.

Photo of Ronnie Cowan Ronnie Cowan Shadow SNP Spokesperson (Infrastructure)

When the Government announced that they were prepared to allow medical cannabis under prescription, the decision was welcomed by many people throughout the United Kingdom who suffer from a range of conditions, but the process that has been adopted has failed to deliver. When will the Government take steps to facilitate GPs to prescribe and pharmacists to provide the appropriate effective forms of medical cannabis?

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

We commissioned the National Institute for Health and Care Excellence to produce further guidance that should be out by October. Doctors are right to be cautious when the evidence base remains limited and further research in this area is vital. The change to the law will facilitate that. The National Institute for Health Research has called for research proposals to enhance our knowledge in the area and I think that that is absolutely right.